Cabaletta Bio Inc
NASDAQ:CABA

Watchlist Manager
Cabaletta Bio Inc Logo
Cabaletta Bio Inc
NASDAQ:CABA
Watchlist
Price: 2.39 USD -0.83% Market Closed
Market Cap: 230.1m USD

Operating Margin
Cabaletta Bio Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-163m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Cabaletta Bio Inc
Glance View

Market Cap
230.1m USD
Industry
Biotechnology

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania and currently employs 53 full-time employees. The company went IPO on 2019-10-25. The firm is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. The firm's lead CAAR T cell product candidate is designed based on chimeric antigen receptor (CAR), and its T cell technology has been developed and is marketed for the treatment of B cell cancers. The firm has discovered and developed four product candidates, including its lead product candidate, to potentially treat patients with mucosal pemphigus vulgaris (mPV), and three additional product candidates that have demonstrated specific and selective target engagement in vitro. Its product pipelines include DSG3-CAART, DSG3/1-CAART, Musk-CAART and FVIII-CAART.

CABA Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-163m
/
Revenue
0
What is the Operating Margin of Cabaletta Bio Inc?

Based on Cabaletta Bio Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top